Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · IEX Real-Time Price · USD
32.36
+0.47 (1.47%)
At close: Jun 11, 2024, 4:00 PM
32.75
+0.39 (1.21%)
After-hours: Jun 11, 2024, 4:22 PM EDT
ARCT Market Cap
ARCT has a market cap or net worth of $871.51 million as of June 11, 2024. Its market cap has increased by 21.19% in one year.
Market Cap
871.51M
Enterprise Value
557.65M
1-Year Change
21.19%
Ranking
Category
Stock Price
$32.36
Market Cap Chart
Since October 22, 2013, ARCT's market cap has increased from $222.10M to $871.51M, an increase of 292.40%. That is a compound annual growth rate of 13.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 7, 2024 | 857.00M | -25.30% |
Jun 6, 2024 | 1.15B | -4.03% |
Jun 5, 2024 | 1.20B | 7.17% |
Jun 4, 2024 | 1.12B | 1.87% |
Jun 3, 2024 | 1.10B | 4.76% |
May 31, 2024 | 1.05B | 0.86% |
May 30, 2024 | 1.04B | 4.79% |
May 29, 2024 | 988.90M | -4.41% |
May 28, 2024 | 1.03B | 26.31% |
May 24, 2024 | 819.00M | -2.56% |
May 23, 2024 | 840.50M | -3.62% |
May 22, 2024 | 872.10M | 8.48% |
May 21, 2024 | 803.90M | -2.13% |
May 20, 2024 | 821.40M | 2.42% |
May 17, 2024 | 802.00M | -2.36% |
May 16, 2024 | 821.40M | 5.12% |
May 15, 2024 | 781.40M | -2.45% |
May 14, 2024 | 801.00M | 3.56% |
May 13, 2024 | 773.50M | 5.35% |
May 10, 2024 | 734.20M | 1.76% |
May 9, 2024 | 721.50M | -1.54% |
May 8, 2024 | 732.80M | -1.21% |
May 7, 2024 | 741.80M | 0.88% |
May 6, 2024 | 735.30M | 0.18% |
May 3, 2024 | 734.00M | 2.83% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cassava Sciences | 902.43M |
Arcutis Biotherapeutics | 900.64M |
Prime Medicine | 890.63M |
Abivax | 886.51M |
Silk Road Medical | 873.68M |
ARS Pharmaceuticals | 869.15M |
Viridian Therapeutics | 859.05M |
Pharvaris | 854.61M |